Cargando…
Cyclin C: A new responser for chemosensitivity in cancer
The resistance to cisplatin‐based chemotherapy is a common cause of poor prognosis in cancer patients. Cisplatin stimulation causes cyclin C translocating to mitochondria, and in turn induces mitochondrial fission. However, little is known about the role of cyclin C in mitochondrial dysfunction in c...
Autores principales: | Fang, Shuai, Jin, Xiaofeng, Zhou, Chengwei, Gong, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042672/ https://www.ncbi.nlm.nih.gov/pubmed/35475325 http://dx.doi.org/10.1002/ctm2.833 |
Ejemplares similares
-
NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
por: Kiesslich, Tobias, et al.
Publicado: (2019) -
2-Hydroxylated fatty acids as candidates of novel drugs to promote chemosensitivity of gastric cancer
por: Tsuboi, Kazuhito
Publicado: (2019) -
Cyclins in breast cancer: too much of a good thing
por: Enders, Greg H
Publicado: (2002) -
Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models
por: Sutherland, Robert L, et al.
Publicado: (2002) -
Cyclin A2, Rho GTPases and EMT
por: Bendris, Nawal, et al.
Publicado: (2012)